www.fdanews.com/articles/199345-oraldna-labs-wins-emergency-authorization-for-covid-19-oral-rinse-test
![emergency use authorization approved](https://www.fdanews.com/ext/resources/test/Drug-Images4/thumb/emergency-use-authorization-EUA-approved.gif?t=1586211473&width=261)
OralDNA Labs Wins Emergency Authorization for COVID-19 Oral Rinse Test
October 2, 2020
Minnesota-based OralDNA Labs has received an Emergency Use Authorization from the FDA for its coronavirus saline oral rinse test.
The OraRisk COVID-19 real-time polymerase chain reaction tests offers an alternative to nasal swab and saliva direct testing. The product identifies nucleic acid from SARS-CoV-2 in culture specimens.
Samples can remain viable for up to 72 hours and they do not need to be transported under refrigeration, the company said.